Central Asian Research Index

Journal of Clinical Medicine of Kazakhstan, 2026, т. 23, № 5, с. 76-80

Factors Associated with Hepatitis C Treatment Failure: a Regional Case-Control Study in Kazakhstan

Arailym Maikenova, Alexander V. Nersesov, Aigul Raissova, Elmira Kuantay, Malika Aznabakiyeva, Aisulu Gainutdin, Nazugum Ashimova

Department of Gastroenterology, Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan; Institute of Gastroenterology, Hepatology and Metabolism "Interna Clinic", Almaty, Republic of Kazakhstan
Department of Gastroenterology, Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan; Institute of Gastroenterology, Hepatology and Metabolism "Interna Clinic", Almaty, Republic of Kazakhstan; Hepatological Center of Almaty, Republic of Kazakhstan
Institute of Gastroenterology, Hepatology and Metabolism "Interna Clinic", Almaty, Republic of Kazakhstan

Аннотация · Abstract

<b>Introduction:</b> Direct-acting antiviral therapy achieves high cure rates in chronic hepatitis C; however, a minority of patients do not achieve a sustained virologic response. The aim of this study was to evaluate clinical, demographic, and virologic factors associated with failure to achieve a sustained virologic response among patients with chronic hepatitis C treated in the Turkestan Region of Kazakhstan.<br /> <b>Methods:</b> We performed a retrospective case-control study of 168 adults treated with direct-acting antivirals between January 2018 and December 2022. The control group comprised 126 patients who achieved a sustained virologic response, and the case group comprised 42 patients without a sustained virologic response. Demographic characteristics, disease duration, treatment duration, adherence, hepatitis C virus genotype, pretreatment alanine aminotransferase level, liver elastography, and fibrosis stage were analyzed.<br /> <b>Results:</b> Patients without a sustained virologic response had higher pretreatment alanine aminotransferase levels (p=0.03), higher liver stiffness values on elastography (p=0.007), and a longer duration of chronic hepatitis C before treatment (p&lt;0.0001). Genotype 3 was more frequent among cases than controls (59.5% vs 24.6%; p&lt;0.0001), and F4 fibrosis was also more common (40.5% vs 10.3%; p&lt;0.0001). Treatment duration greater than 12 weeks (p=0.02) and lower treatment adherence (p&lt;0.0001) were more frequent in the case group. Age, sex, ethnicity, and previous pegylated interferon/ribavirin therapy did not differ significantly between groups.<br /> <b>Conclusion:</b> Failure to achieve a sustained virologic response was associated with greater biochemical activity, more advanced liver fibrosis, longer disease duration, genotype 3 infection, and lower treatment adherence. Adherence represents a potentially modifiable factor that may be addressed through structured follow-up and patient counseling.

Сведения · Details